The landscape of cancer treatment is rapidly evolving with advancements in precision medicine, immunotherapy, and targeted therapies. These innovations are transforming cancer care by providing more personalized and effective treatment options. However, the accessibility of these advanced treatments varies significantly across different regions, with LMICs often lagging behind.
